Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidong Kim

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
AJR. American Journal of Roentgenology|April 14, 2021
Establishing Normal Testicular <sup>18</sup>F-FDG PET/CT SUVsLaura Harper, Curtis Simmons, Mark Nathan, et al.
Scientific Reports|November 5, 2017
Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumabJohn T Butterfield, Hidong Kim, Daniel J Knauer, et al.
Geriatrics & Gerontology International|March 28, 2013
Frailty assessment in the geriatric outpatient clinicHidong Kim, Patricia A Higgins, David H Canaday, et al.
Journal of Medical Cases|September 9, 2014
Treatment of Cholesterol Embolization Syndrome in the Setting of an Acute Indication for Anticoagulation TherapyHidong Kim, David B Zhen, John C Lieske, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|September 10, 2011
An ensemble of structures of Burkholderia pseudomallei 2,3-bisphosphoglycerate-dependent phosphoglycerate mutaseDouglas R Davies, Bart L Staker, Jan A Abendroth, et al.
Protein Science : a Publication of the Protein Society|March 25, 2008
Design of an engineered N-terminal HIV-1 gp41 trimer with enhanced stability and potencyJohn J Dwyer, Karen L Wilson, Kimberly Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2009
Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion proteinDirk Roymans, Hendrik L De Bondt, Eric Arnoult, et al.
Journal of Medicinal Chemistry|July 22, 2009
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallographyDouglas R Davies, Bjorn Mamat, Olafur T Magnusson, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge regionYu Mi Ahn, Michael Clare, Carol L Ensinger, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
AJR. American Journal of Roentgenology|April 14, 2021
Establishing Normal Testicular <sup>18</sup>F-FDG PET/CT SUVsLaura Harper, Curtis Simmons, Mark Nathan, et al.
Scientific Reports|November 5, 2017
Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumabJohn T Butterfield, Hidong Kim, Daniel J Knauer, et al.
Geriatrics & Gerontology International|March 28, 2013
Frailty assessment in the geriatric outpatient clinicHidong Kim, Patricia A Higgins, David H Canaday, et al.
Journal of Medical Cases|September 9, 2014
Treatment of Cholesterol Embolization Syndrome in the Setting of an Acute Indication for Anticoagulation TherapyHidong Kim, David B Zhen, John C Lieske, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|September 10, 2011
An ensemble of structures of Burkholderia pseudomallei 2,3-bisphosphoglycerate-dependent phosphoglycerate mutaseDouglas R Davies, Bart L Staker, Jan A Abendroth, et al.
Protein Science : a Publication of the Protein Society|March 25, 2008
Design of an engineered N-terminal HIV-1 gp41 trimer with enhanced stability and potencyJohn J Dwyer, Karen L Wilson, Kimberly Martin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2009
Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion proteinDirk Roymans, Hendrik L De Bondt, Eric Arnoult, et al.
Journal of Medicinal Chemistry|July 22, 2009
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallographyDouglas R Davies, Bjorn Mamat, Olafur T Magnusson, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge regionYu Mi Ahn, Michael Clare, Carol L Ensinger, et al.
Pageof 1